Literature DB >> 24859783

Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis.

Patompong Ungprasert1, Prangthip Charoenpong, Praveen Ratanasrimetha, Charat Thongprayoon, Wisit Cheungpasitporn, Promporn Suksaranjit.   

Abstract

Several chronic inflammatory disorders, such as rheumatoid arthritis and systemic lupus erythematosus, have been shown to increase coronary artery disease (CAD) risk but the data on systemic sclerosis (SSc) is unclear. We conducted a systematic review and meta-analysis of observational studies that reported odds ratio, relative risk, hazard ratio, or standardized incidence ratio comparing CAD risk in patients with SSc versus non-SSc participants. Pooled risk ratio and 95 % confidence intervals were calculated using a random effect, generic inverse variance method. Four studies were identified and included in our data analysis. The pooled risk ratio of CAD in patients with SSc was 1.82 (95 % CI, 1.40 to 2.36). The statistical heterogeneity of this meta-analysis was moderate with an I (2) of 73 %. Our study demonstrated a statistically significant increased CAD risk among patients with SSc.

Entities:  

Mesh:

Year:  2014        PMID: 24859783     DOI: 10.1007/s10067-014-2681-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

Review 1.  Risk of coronary artery disease in patients with idiopathic inflammatory myopathies: a systematic review and meta-analysis of observational studies.

Authors:  Patompong Ungprasert; Promporn Suksaranjit; Ittikorn Spanuchart; Napat Leeaphorn; Nitipong Permpalung
Journal:  Semin Arthritis Rheum       Date:  2014-03-06       Impact factor: 5.532

2.  Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis.

Authors:  Gene-Siew Ngian; Joanne Sahhar; Susanna M Proudman; Wendy Stevens; Ian P Wicks; Sharon Van Doornum
Journal:  Ann Rheum Dis       Date:  2012-04-24       Impact factor: 19.103

Review 3.  Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis.

Authors:  F Montecucco; F Mach
Journal:  Rheumatology (Oxford)       Date:  2008-10-16       Impact factor: 7.580

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 5.  Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality.

Authors:  Udi Nussinovitch; Yehuda Shoenfeld
Journal:  Autoimmun Rev       Date:  2010-09-21       Impact factor: 9.754

6.  Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study.

Authors:  Szu-Ying Chu; Yi-Ju Chen; Chia-Jen Liu; Wei-Cheng Tseng; Ming-Wei Lin; Chian-Yaw Hwang; Chih-Chiang Chen; Ding-Dar Lee; Tzeng-Ji Chen; Yun-Ting Chang; Wen-Jen Wang; Han-Nan Liu
Journal:  Am J Med       Date:  2013-11       Impact factor: 4.965

Review 7.  Atherosclerosis in patients with autoimmune disorders.

Authors:  Johan Frostegård
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-23       Impact factor: 8.311

Review 8.  Inflammation, innate immunity and blood coagulation.

Authors:  J Xu; F Lupu; C T Esmon
Journal:  Hamostaseologie       Date:  2010-01       Impact factor: 1.778

9.  The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study.

Authors:  Ada Man; Yanyan Zhu; Yuqing Zhang; Maureen Dubreuil; Young Hee Rho; Christine Peloquin; Robert W Simms; Hyon K Choi
Journal:  Ann Rheum Dis       Date:  2012-08-17       Impact factor: 19.103

10.  Risk of subsequent coronary heart disease in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

View more
  18 in total

1.  Reliability of Cardiovascular Risk Calculators to Estimate Accurately the Risk of Cardiovascular Disease in Patients With Sarcoidosis.

Authors:  Patompong Ungprasert; Eric L Matteson; Cynthia S Crowson
Journal:  Am J Cardiol       Date:  2017-06-15       Impact factor: 2.778

2.  Risk of coronary artery disease in patients with ankylosing spondylitis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Narat Srivali; Wonngarm Kittanamongkolchai
Journal:  Ann Transl Med       Date:  2015-03

3.  Epicardial adipose tissue thickness in systemic sclerosis patients without overt cardiac disease.

Authors:  Duygu Temiz Karadag; Tayfun Sahin; Senem Tekeoglu; Ozlem Ozdemir Isik; Ayten Yazici; Ayse Cefle
Journal:  Rheumatol Int       Date:  2019-04-25       Impact factor: 2.631

Review 4.  Managing premature atherosclerosis in patients with chronic inflammatory diseases.

Authors:  Alexandra Legge; John G Hanly
Journal:  CMAJ       Date:  2018-04-09       Impact factor: 8.262

Review 5.  Chronic inflammatory diseases, myocardial function and cardioprotection.

Authors:  Antigone Lazou; Ignatios Ikonomidis; Monika Bartekova; Theodora Benedek; George Makavos; Dimitra Palioura; Hector Cabrera Fuentes; Ioanna Andreadou
Journal:  Br J Pharmacol       Date:  2020-02-08       Impact factor: 8.739

6.  Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study.

Authors:  Chao-Han Lai; Cheng-Yang Hsieh; April Barnado; Li-Ching Huang; Sheau-Chiann Chen; Liang-Miin Tsai; Yu Shyr; Chung-Yi Li
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

Review 7.  Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.

Authors:  Justin C Mason; Peter Libby
Journal:  Eur Heart J       Date:  2014-11-27       Impact factor: 29.983

Review 8.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

Review 9.  Comorbidity burden in systemic sclerosis: beyond disease-specific complications.

Authors:  Eleni Pagkopoulou; Alexandra Arvanitaki; Dimitrios Daoussis; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2019-07-12       Impact factor: 2.631

Review 10.  Polymyalgia rheumatica and risk of coronary artery disease: a systematic review and meta-analysis of observational studies.

Authors:  Patompong Ungprasert; Matthew J Koster; Kenneth J Warrington; Eric L Matteson
Journal:  Rheumatol Int       Date:  2016-08-30       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.